Blue Water Vaccines (BWV) –
-
Form 10-Q Blue Water Biotech, Inc. For: Sep 30
-
Form NT 10-Q Blue Water Biotech, Inc. For: Sep 30
-
Blue Water Vaccines (BWV) to Acquire a Commercial Stage Oncology Company
-
Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company
-
Form 8-K Blue Water Biotech, Inc. For: Nov 02
-
Blue Water Vaccines (BWV) Regains Nasdaq Compliance
-
Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)
-
Form 8-K Blue Water Biotech, Inc. For: Oct 30
-
Blue Water Vaccines (BWV) CEO Issues Letter to Shareholders
-
Blue Water Biotech Issues Letter to Shareholders
-
Form 10-Q Blue Water Biotech, Inc. For: Jun 30
-
Form 8-K Blue Water Biotech, Inc. For: Oct 12
-
Form 3 Blue Water Biotech, Inc. For: Oct 04 Filed by: CAMPBELL NEIL J
-
Form 3 Blue Water Biotech, Inc. For: Oct 04 Filed by: Harmon Bruce
-
Blue Water Vaccines (BWV) Appoints Neil Campbell as CEO and President
-
Form 8-K Blue Water Biotech, Inc. For: Oct 04
-
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
-
Form 8-K Blue Water Biotech, Inc. For: Sep 21
-
Form 8-K Blue Water Biotech, Inc. For: Sep 18
-
Maxim Group Downgrades Blue Water Vaccines Inc. (BWV) to Hold
-
Form 8-K Blue Water Biotech, Inc. For: Sep 02
-
Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q
-
Form 8-K Blue Water Biotech, Inc. For: Aug 22
-
Blue Water Vaccines (BWV) Announces CEO Resignation
-
Form 8-K Blue Water Biotech, Inc. For: Aug 16
-
Form NT 10-Q Blue Water Biotech, Inc. For: Jun 30
-
Form 8-K Blue Water Biotech, Inc. For: Aug 10
-
Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial Products
-
Form 8-K Blue Water Biotech, Inc. For: Aug 01
-
Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds
-
Form 8-K Blue Water Biotech, Inc. For: Jul 31
-
Blue Water Vaccines (BWV) Announces Exercise of Warrants, New $2.7M Private Warrant Placement
-
Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds
-
Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians
-
Form 8-K Blue Water Biotech, Inc. For: Jul 31
-
Form 8-K Blue Water Biotech, Inc. For: Jul 25
-
Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®
-
Form 8-K Blue Water Biotech, Inc. For: Jul 21
-
Form 8-K Blue Water Biotech, Inc. For: Jul 17
-
Blue Water Biotech (BWV) Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
-
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
-
Form 8-K Blue Water Biotech, Inc. For: Jul 11
-
Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support
-
Form 8-K Blue Water Biotech, Inc. For: Jul 06
-
Blue Water Vaccines (BWV) Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products
-
Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products
-
Form 8-K Blue Water Biotech, Inc. For: Jun 29
-
Form 8-K Blue Water Biotech, Inc. For: Jul 06
-
Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio
-
Form SC 13D Blue Water Biotech, Inc. Filed by: Cincinnati Cornerstone Investors BWV I, LLC
Back to BWV Stock Lookup